User login
1. US Department of Veterans Affairs. Mammogram/breast health. March 28, 2022. Accessed January 10, 2024. https://www.womenshealth.va.gov/topics/mammogram-breast-health.asp
2. First anniversary of Mammography and Medical Options Act (MAMMO Act). VA News. June 6, 2023. Accessed January 10, 2024. https://news.va.gov/120476/anniversary-mammography-and-medicaloptions-act/
3. Moss HA, Rasmussen, KM, Patil, V, et al. Demographic characteristics of veterans diagnosed with breast and gynecologic cancers: a comparative analysis with the general population. Abstract presented at: Annual Meeting of the Association of VA Hematology/ Oncology (AVAHO); September 29–October 1, 2023; Chicago, IL. Abstract 47.
4. US Department of Veterans Affairs. Racial and ethnic minority veterans. Updated July 9, 2020. Accessed January 10, 2024. https:// www.va.gov/HEALTHEQUITY/Race_Ethnicity.asp
5. Stringer-Reasor EM, Elkhanany A, Khoury K, Simon MA, Newman LA. Disparities in breast cancer associated with African American identity. Am Soc Clin Oncol Educ Book. 2021;41:e29-e46. doi:10.1200/EDBK_319929
6. Landry I, Sumbly V, Vest M. Advancements in the treatment of triple- CANCER DATA TRENDS 2024 MARCH 2024 • FEDERAL PRACTITIONER negative breast cancer: a narrative review of the literature. Cureus. 2022;14(2):e21970. doi:10.7759/cureus.21970
7. Schlam I, Tolaney SM, Tarantino P. How I treat HER2-low advanced breast cancer. Breast. 2023;67:116-123. doi:10.1016/j.breast.2023.01.005
8. Modi S, Jacot W, Yamashita T, et al; for the DESTINY-Breast04 Trial Investigators. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer. N Engl J Med. 2022;387(1):9-20. doi:10.1056/NEJMoa2203690
1. US Department of Veterans Affairs. Mammogram/breast health. March 28, 2022. Accessed January 10, 2024. https://www.womenshealth.va.gov/topics/mammogram-breast-health.asp
2. First anniversary of Mammography and Medical Options Act (MAMMO Act). VA News. June 6, 2023. Accessed January 10, 2024. https://news.va.gov/120476/anniversary-mammography-and-medicaloptions-act/
3. Moss HA, Rasmussen, KM, Patil, V, et al. Demographic characteristics of veterans diagnosed with breast and gynecologic cancers: a comparative analysis with the general population. Abstract presented at: Annual Meeting of the Association of VA Hematology/ Oncology (AVAHO); September 29–October 1, 2023; Chicago, IL. Abstract 47.
4. US Department of Veterans Affairs. Racial and ethnic minority veterans. Updated July 9, 2020. Accessed January 10, 2024. https:// www.va.gov/HEALTHEQUITY/Race_Ethnicity.asp
5. Stringer-Reasor EM, Elkhanany A, Khoury K, Simon MA, Newman LA. Disparities in breast cancer associated with African American identity. Am Soc Clin Oncol Educ Book. 2021;41:e29-e46. doi:10.1200/EDBK_319929
6. Landry I, Sumbly V, Vest M. Advancements in the treatment of triple- CANCER DATA TRENDS 2024 MARCH 2024 • FEDERAL PRACTITIONER negative breast cancer: a narrative review of the literature. Cureus. 2022;14(2):e21970. doi:10.7759/cureus.21970
7. Schlam I, Tolaney SM, Tarantino P. How I treat HER2-low advanced breast cancer. Breast. 2023;67:116-123. doi:10.1016/j.breast.2023.01.005
8. Modi S, Jacot W, Yamashita T, et al; for the DESTINY-Breast04 Trial Investigators. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer. N Engl J Med. 2022;387(1):9-20. doi:10.1056/NEJMoa2203690
1. US Department of Veterans Affairs. Mammogram/breast health. March 28, 2022. Accessed January 10, 2024. https://www.womenshealth.va.gov/topics/mammogram-breast-health.asp
2. First anniversary of Mammography and Medical Options Act (MAMMO Act). VA News. June 6, 2023. Accessed January 10, 2024. https://news.va.gov/120476/anniversary-mammography-and-medicaloptions-act/
3. Moss HA, Rasmussen, KM, Patil, V, et al. Demographic characteristics of veterans diagnosed with breast and gynecologic cancers: a comparative analysis with the general population. Abstract presented at: Annual Meeting of the Association of VA Hematology/ Oncology (AVAHO); September 29–October 1, 2023; Chicago, IL. Abstract 47.
4. US Department of Veterans Affairs. Racial and ethnic minority veterans. Updated July 9, 2020. Accessed January 10, 2024. https:// www.va.gov/HEALTHEQUITY/Race_Ethnicity.asp
5. Stringer-Reasor EM, Elkhanany A, Khoury K, Simon MA, Newman LA. Disparities in breast cancer associated with African American identity. Am Soc Clin Oncol Educ Book. 2021;41:e29-e46. doi:10.1200/EDBK_319929
6. Landry I, Sumbly V, Vest M. Advancements in the treatment of triple- CANCER DATA TRENDS 2024 MARCH 2024 • FEDERAL PRACTITIONER negative breast cancer: a narrative review of the literature. Cureus. 2022;14(2):e21970. doi:10.7759/cureus.21970
7. Schlam I, Tolaney SM, Tarantino P. How I treat HER2-low advanced breast cancer. Breast. 2023;67:116-123. doi:10.1016/j.breast.2023.01.005
8. Modi S, Jacot W, Yamashita T, et al; for the DESTINY-Breast04 Trial Investigators. Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer. N Engl J Med. 2022;387(1):9-20. doi:10.1056/NEJMoa2203690
